As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181
DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.
vaxart
Companies Rush to Create Swine Flu Vaccines
With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.